These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31995008)

  • 21. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
    Naesens L; Zoulim F
    Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
    Ye N; Chen H; Wold EA; Shi PY; Zhou J
    ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unabated synthesis of new nucleoside analogues with antiviral potential: a tribute to Morris J. Robins.
    De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):586-600. PubMed ID: 20183603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The program of antiviral agents inhibits virus infection.
    Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
    Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and evaluation of thiazolidinone derivatives as antimicrobial and anti-viral agents.
    Ravichandran V; Jain A; Kumar KS; Rajak H; Agrawal RK
    Chem Biol Drug Des; 2011 Sep; 78(3):464-70. PubMed ID: 21615706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoids: promising natural compounds against viral infections.
    Zakaryan H; Arabyan E; Oo A; Zandi K
    Arch Virol; 2017 Sep; 162(9):2539-2551. PubMed ID: 28547385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress for the synthesis of selected carbocyclic nucleosides.
    Bessières M; Chevrier F; Roy V; Agrofoglio LA
    Future Med Chem; 2015; 7(13):1809-28. PubMed ID: 26416300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug targets in viral infections.
    Sabatier JM
    Infect Disord Drug Targets; 2009 Apr; 9(2):100. PubMed ID: 19275697
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and antiviral activity of novel fluorinated 2',3'-dideoxynucleosides.
    Kumar P; Ohkura K; Balzarini J; De Clercq E; Seki K; Wiebe LI
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):7-29. PubMed ID: 15043133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects.
    Dhama K; Karthik K; Khandia R; Munjal A; Tiwari R; Rana R; Khurana SK; Sana Ullah ; Khan RU; Alagawany M; Farag MR; Dadar M; Joshi SK
    Curr Drug Metab; 2018; 19(3):236-263. PubMed ID: 29380697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Quinolone hybrids and their antibacterial activities.
    Hu YQ; Zhang S; Xu Z; Lv ZS; Liu ML; Feng LS
    Eur J Med Chem; 2017 Dec; 141():335-345. PubMed ID: 29031077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral activity of resveratrol.
    Campagna M; Rivas C
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):50-3. PubMed ID: 20074034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid synthesis of 2',3'-dideoxy-3'β-fluoro-pyrimidine nucleosides from 2'-deoxypyrimidine nucleosides.
    Khalil A; Mathé C; Périgaud C
    Bioorg Chem; 2010 Dec; 38(6):271-4. PubMed ID: 20869741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Updates on the Role of Nanoparticles in the Treatment of Viral Diseases.
    Javaid A; Zahra D; Asim A; Javaid N; Ashfaq UA
    Crit Rev Ther Drug Carrier Syst; 2021; 38(2):75-102. PubMed ID: 33639068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
    Brooks MJ; Sasadeusz JJ; Tannock GA
    Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential targets for antiviral chemotherapy.
    Prusoff WH; Lin TS; Zucker M
    Antiviral Res; 1986 Oct; 6(6):311-28. PubMed ID: 3535669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antiviral evaluation of α-D-2',3'-didehydro-2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
    Yamada K; Hayakawa H; Sakata S; Ashida N; Yoshimura Y
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6013-6. PubMed ID: 20833044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.